Joshua M. Eichhorn
Assistant Professor
faculty
Radiology, College of Medicine
Research Areas
Biography and Research Information
OverviewAI-generated summary
Joshua M. Eichhorn is an Assistant Professor in the Department of Radiology at the University of Arkansas for Medical Sciences. His research interests include medical imaging techniques and applications, with a focus on utilizing advanced imaging modalities for diagnosis and monitoring of various medical conditions. He has explored applications of positron emission tomography computed tomography (PET/CT) and X-ray computed tomography (CT) in his work. Recent publications include studies on automated skeleton segmentation from whole-body CT images, the detection of prostate cancer metastasis, and the use of imaging in diagnosing systemic neurosarcoidosis and multiple myeloma. He also investigates resting-state brain metabolic fingerprinting as a potential biomarker for major depression in multiple myeloma patients. Eichhorn has a h-index of 7, with 38 publications and 408 citations. He collaborates with several researchers at the University of Arkansas for Medical Sciences, including Timothy C. Chambers and Fathima Fijula Palot Manzil.
Metrics
- h-index: 7
- Publications: 39
- Citations: 417
Selected Publications
-
Multimodal reprogramming of the tumor microenvironment by MMR and dual checkpoint blockade in hepatocellular carcinoma models (2025)
-
Mandibular Condylar Hyperplasia Diagnosed With 99mTcMDP SPECT/CT (2025)
-
Evaluation of Rare Insulin-derived Amyloidoma With 18F-FDG PET/CT (2025)
-
Evaluating Skellytour for Automated Skeleton Segmentation from Whole-Body CT Images (2025)
-
99mTc-Sestamibi SPECT/CT Evaluation of Renal Oncocytomas (2024)
-
Retroperitoneal Malakoplakia Mimicking Metastatic Disease (2024)
-
Perinephric Extramedullary Disease in Multiple Myeloma (2024)
-
18F-FDG, 68Ga-PSMA, and 64Cu-DOTATATE PET/CT—One Patient, Three Cancers (2024)
-
Systemic and Neurosarcoidosis With Rare Involvement of the Extremities’ Peripheral Nerves (2024)
-
Prostate-Specific Membrane Antigen PET/CT Detection of Prostate Cancer Metastasis to Thyroid and Cricoid Cartilages (2024)
-
10-year update to the combined 16-month nuclear medicine and diagnostic radiology residency: The NuRad pathway (2024)
-
Giant left pheochromocytoma with vascular anomalies and pelvic horseshoe kidney: a case report (2023)
-
Scintigraphic Detection of Abdominal Pseudocyst: A Complication of Ventriculoperitoneal Shunt (2023)
-
Synchronous Ectopic Thyroid Gland and Ectopic Parathyroid Adenoma on<sup>99m</sup>Tc-Sestamibi Scintigraphy and Correlative Imaging (2023)
-
Polyostotic Paget Disease (2023)
Grants & Funding
- Bcl-2 Proteins in Mechanism of Anti-mitotic Drug Action NIH Co-Investigator
- Osteocytes in Osteogenesis imperfecta CMDR Co-Investigator
Collaboration Network
Top Collaborators
- Supplemental Figure 1 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 5 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplementary Material from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 3 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 2 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
Showing 5 of 14 shared publications
- Supplemental Figure 1 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 5 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplementary Material from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 3 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 2 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
Showing 5 of 14 shared publications
- Supplemental Figure 1 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 5 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplementary Material from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 3 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 2 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
Showing 5 of 14 shared publications
- Supplemental Figure 1 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 5 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplementary Material from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 3 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 2 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
Showing 5 of 14 shared publications
- Supplemental Figure 1 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 5 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplementary Material from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 3 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 2 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
Showing 5 of 14 shared publications
- Supplemental Figure 1 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 5 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplementary Material from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 3 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 2 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
Showing 5 of 14 shared publications
- Supplemental Figure 1 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 5 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplementary Material from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 3 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 2 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
Showing 5 of 14 shared publications
- Supplemental Figure 1 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 5 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplementary Material from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 3 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 2 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
Showing 5 of 14 shared publications
- Supplemental Figure 1 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 5 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplementary Material from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 3 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- Supplemental Figure 2 from BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
Showing 5 of 14 shared publications
- Synchronous Ectopic Thyroid Gland and Ectopic Parathyroid Adenoma on<sup>99m</sup>Tc-Sestamibi Scintigraphy and Correlative Imaging
- Evaluating Skellytour for Automated Skeleton Segmentation from Whole-Body CT Images
- Prostate-Specific Membrane Antigen PET/CT Detection of Prostate Cancer Metastasis to Thyroid and Cricoid Cartilages
- Systemic and Neurosarcoidosis With Rare Involvement of the Extremities’ Peripheral Nerves
- Perinephric Extramedullary Disease in Multiple Myeloma
Showing 5 of 11 shared publications
- Polyostotic Paget Disease
- 10-year update to the combined 16-month nuclear medicine and diagnostic radiology residency: The NuRad pathway
- Prostate-Specific Membrane Antigen PET/CT Detection of Prostate Cancer Metastasis to Thyroid and Cricoid Cartilages
- 99mTc-Sestamibi SPECT/CT Evaluation of Renal Oncocytomas
- Resting-state brain metabolic fingerprinting clusters (biomarkers) and predictive models for major depression in multiple myeloma patients
- Resting-state brain metabolic fingerprinting clusters (biomarkers) and predictive models for major depression in multiple myeloma patients
- Resting-state brain metabolic fingerprinting clusters (biomarkers) and predictive models for major depression in multiple myeloma patients
Similar Researchers
Based on overlapping research topics